Clinical trial
A Study of ATG-201 in Adult Participants With Autoimmune Diseases
NCT07732309
Study timeline
Study start (estimated)2026-09-01Date precision: day
Registry last updated2026-09-21
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Systemic Lupus Erythematosusunresolved
Systemic Sclerosis (SSc)unresolved
Sjogren's Diseaseunresolved
Autoimmune Diseasesunresolved
Interventions
ATG-201DRUG
Sponsors & collaborators
Antengene Biologics Limitedlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07732309 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.